Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Samsung Medical Center
Samsung Medical Center
Centre Hospitalier Universitaire, Amiens
University of Washington
Azienda USL Reggio Emilia - IRCCS
Johnson & Johnson (China) Investment Ltd.
University of Washington
Creative Biosciences (Guangzhou) Co., Ltd.
University of Washington
Centre Hospitalier Universitaire de Nice
TidalSense
Mayo Clinic
Lund University
CHU de Reims
Weprom
University of Washington
Heart of England NHS Trust
Asan Medical Center
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz
University Hospital, Limoges
Hopital Foch
Weill Medical College of Cornell University
Weill Medical College of Cornell University
VA Office of Research and Development
University of Milan
The Miriam Hospital
Schillerhoehe Hospital